- Home
- Publications
- Publication Search
- Publication Details
Title
What Is New in Cutaneous T Cell Lymphoma?
Authors
Keywords
-
Journal
Current Oncology Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-24
DOI
10.1007/s11912-023-01464-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma
- (2023) Mathias Oymanns et al. BRITISH JOURNAL OF DERMATOLOGY
- Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics
- (2023) Lukas Peiffer et al. Frontiers in Oncology
- Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment
- (2023) Yumei Gao et al. JCI Insight
- Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
- (2023) Adèle de Masson et al. LANCET
- Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma
- (2023) Eirini Kalliara et al. Cancers
- An Update on Recent Advances of Photodynamic Therapy for Primary Cutaneous Lymphomas
- (2023) Wei-Ting Liu et al. Pharmaceutics
- Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardised approach
- (2022) Maarten H. Vermeer et al. BRITISH JOURNAL OF DERMATOLOGY
- Downregulation of miR‐26 promotes invasion and metastasis via targeting interleukin‐22 in cutaneous T‐cell lymphoma
- (2022) Yuka Matsuda et al. CANCER SCIENCE
- Author Correction: Visualizing group II intron dynamics between the first and second steps of splicing
- (2022) Jacopo Manigrasso et al. Nature Communications
- The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas
- (2022) JJ Scarisbrick PRESSE MEDICALE
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
- (2022) Ellen J. Kim et al. JAMA Dermatology
- Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signalling in cutaneous T-cell lymphoma
- (2022) Maria Gluud et al. BLOOD
- Prognostic factors in mycosis fungoides and Sezary syndrome: results from the PROCLIPI study
- (2022) JJ Scarisbrick et al. EUROPEAN JOURNAL OF CANCER
- CD8+ T Lymphocytes in Hypopigmented Mycosis Fungoides: Malignant Cells or Reactive Clone?
- (2022) Simon Cao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mogamulizumab‐associated rashes, their presentation and prognostic significance: a single‐centre retrospective case series analysis
- (2022) Alessandro Pileri et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
- (2021) E. Domingo-Domenech et al. BONE MARROW TRANSPLANTATION
- Phase 1 Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
- (2021) Stephen M Ansell et al. CLINICAL CANCER RESEARCH
- Novel therapies targeting cutaneous T cell lymphomas and their microenvironment
- (2021) John C. Reneau et al. SEMINARS IN HEMATOLOGY
- Multimodal single-cell analysis of cutaneous T cell lymphoma reveals distinct sub-clonal tissue-dependent signatures.
- (2021) Alberto Herrera et al. BLOOD
- Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome
- (2021) Safa Najidh et al. BLOOD
- Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
- (2021) Thomas Bieber NATURE REVIEWS DRUG DISCOVERY
- Cutaneous T cell lymphoma
- (2021) Reinhard Dummer et al. Nature Reviews Disease Primers
- Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
- (2021) Steven M. Horwitz et al. Blood Advances
- A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
- (2021) Alison J. Moskowitz et al. BLOOD
- Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
- (2021) Darci Phillips et al. Nature Communications
- Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study
- (2021) Christiane Querfeld et al. Lancet Haematology
- The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides
- (2021) Pengfei Wen et al. Frontiers in Oncology
- Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL
- (2020) Cosmin A Tegla et al. BLOOD
- Regulatory Mechanism of MicroRNA Expression in Cancer
- (2020) Zainab Ali Syeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
- (2020) Neha Mehta-Shah et al. Journal of the National Comprehensive Cancer Network
- MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
- (2020) Maria Gluud et al. Cancers
- Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROCLIPI international Study
- (2020) E. Hodak et al. BRITISH JOURNAL OF DERMATOLOGY
- Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma
- (2020) Aishwarya Iyer et al. Blood Advances
- Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry
- (2020) G. Dobos et al. BRITISH JOURNAL OF DERMATOLOGY
- The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication
- (2020) Joseph S. Durgin et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tumor microenvironment as a therapeutic target in cancer
- (2020) Yi Xiao et al. PHARMACOLOGY & THERAPEUTICS
- The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
- (2019) Rein Willemze et al. BLOOD
- Comparison of Narrowband UV-B With Psoralen–UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides
- (2019) Kevin Phan et al. JAMA Dermatology
- Clonotypic diversity of the T-cell receptor corroborates the immature precursor origin of cutaneous T-cell lymphoma
- (2019) Abdelbasset Hamrouni et al. CLINICAL CANCER RESEARCH
- Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma
- (2019) Lise M. Lindahl et al. BLOOD
- Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy individuals
- (2019) Maria M. Klicznik et al. Science Immunology
- Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma
- (2019) Aishwarya Iyer et al. BLOOD
- Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update
- (2019) Egle Ramelyte et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
- (2019) Michael S. Khodadoust et al. JOURNAL OF CLINICAL ONCOLOGY
- IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
- (2019) Martine Bagot et al. LANCET ONCOLOGY
- Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients
- (2019) Drew A. Emge et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides
- (2019) John T. O'Malley et al. CLINICAL CANCER RESEARCH
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force
- (2018) Julia J. Scarisbrick et al. EUROPEAN JOURNAL OF CANCER
- Folliculotropic mycosis fungoides
- (2018) Christina Mitteldorf et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma
- (2018) D.J. Lewis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile
- (2018) Christiane Querfeld et al. Cancer Immunology Research
- The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients
- (2018) J.J. Scarisbrick et al. BRITISH JOURNAL OF DERMATOLOGY
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
- (2018) Youn H Kim et al. LANCET ONCOLOGY
- New insights into folliculotropic mycosis fungoides (FMF): A single-center experience
- (2016) Emmilia Hodak et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study
- (2016) I.J. Rodney et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
- (2016) Thorbjørn Krejsgaard et al. Seminars in Immunopathology
- Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma
- (2016) Fumito Abe et al. Oncotarget
- Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
- (2016) Ieva Saulite et al. Biomed Research International
- Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides
- (2016) Suzanne van Santen et al. JAMA Dermatology
- New treatment options for mycosis fungoides
- (2016) AlexaRose Shipman et al. INDIAN JOURNAL OF DERMATOLOGY
- Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
- (2015) A. H. Rook et al. BLOOD
- Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma
- (2015) C. Perez et al. HAEMATOLOGICA
- Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature
- (2015) Anne M. Stowman et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Results of a Phase II Trial of Brentuximab Vedotin for CD30+Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis
- (2015) Madeleine Duvic et al. JOURNAL OF CLINICAL ONCOLOGY
- Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides
- (2015) Fernando Gallardo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials
- (2015) Richard T. Hoppe et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The difficult—and often delayed—diagnosis of CTCL
- (2015) Jason Weed et al. Science Translational Medicine
- Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
- (2015) Nina A. Sibbesen et al. Oncotarget
- Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma
- (2015) C. Perez et al. HAEMATOLOGICA
- Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology
- (2014) Fabricio Cecanho Furlan et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
- (2014) Francine Foss et al. BRITISH JOURNAL OF HAEMATOLOGY
- TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell Lymphoma
- (2013) E. Guenova et al. CLINICAL CANCER RESEARCH
- Guidelines on the use of extracorporeal photopheresis
- (2013) R. Knobler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial 21011 (NCT00
- (2012) S. Whittaker et al. BRITISH JOURNAL OF DERMATOLOGY
- Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012
- (2012) Reinhard Dummer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence and Severity of Pruritus and Quality of Life in Patients With Cutaneous T-Cell Lymphoma
- (2012) Abigail Wright et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Pruritus in cutaneous T-cell lymphoma: A review
- (2012) Kristen Ahern et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Acitretin for the treatment of cutaneous T-cell lymphoma
- (2012) Justin Cheeley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
- (2012) T Kalina et al. LEUKEMIA
- Topical Chemotherapy in Cutaneous T-cell Lymphoma
- (2012) Stuart R. Lessin et al. JAMA Dermatology
- Interferon treatment of cutaneous T-cell lymphoma
- (2010) C. Ross et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of microgravity on immune cell viability and proliferation
- (2009) L.K. Martinelli et al. IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE
- Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
- (2008) Gaëlle Quereux et al. ARCHIVES OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started